Kringle Pharma, Inc.
Notice Regarding the Establishment of the Record Date for the Convening of an Extraordinary General Shareholders Meeting
Notice of record date for the extraordinary general meeting to be held in August 2026, with the provisional determination of voting rights as of the record date. Announcement date is June 11, with electronic notification for disclosure. Proposed items for resolution are the reduction of capital and capital surplus, and the disposal of retained earnings; details to be decided at a future board of directors meeting.
Key Figures
- Record date: 2026-06-30
- Announcement date: 2026-06-11
- Scheduled date: in August 2026
- Proposed resolutions: Reduction of capital and capital surplus, and disposal of retained earnings
AI要約
Establishment of the record date for the extraordinary general meeting
This IR communicates the establishment of a record date for the convening of an extraordinary general meeting. The record date is set at 2026-06-30, and shareholders recorded or registered on that date will be eligible to exercise voting rights. Announcement date is 2026-06-11, with electronic disclosure. The extraordinary meeting is scheduled for August 2026.
Proposed resolutions and upcoming schedule
The proposed resolutions for the extraordinary meeting are a reduction of capital and capital surplus, and the disposal of retained earnings. Details will be announced as soon as decided at the upcoming board meeting. The specific timing of future announcements and procedures will be disclosed in due course.
Kringle Pharma Co., Ltd.
Company overview · Stock price · Financial data · All IR
